Home/Hillstar Bio/Shiva Krupa

SK

Shiva Krupa

Vice President of Program Management

Therapeutic Areas

Autoimmune Diseases Immunology

Hillstar Bio Pipeline

Drug	Indication	Phase
HSB-101	Axial Spondyloarthritis (AxSpA) & other HLA-B27-mediated conditions	Preclinical
Undisclosed Immune Cell Depleter	Undisclosed	Lead Optimization

Leadership Team at Hillstar Bio

Douangsone Vadysirisack

Vice President of Immunology

Sr Director, Antibody Research

Executive Chair of the Board

View full Hillstar Bio profile